Factors Mediating the Late Stages of ER-to-Golgi
Transport in Yeast Y. JIANG,' M. SACHER, I B. SINGER-KROGER, 1 J.P. LIAN, 2, S. STONE, I AND S. FERRO-NOVICK 1 1Department of Cell Biology and Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut 06536; 2Center for Radiological Research, Columbia University Medical School, New York, New York 10032 The movement of proteins and lipids between membranous compartments within a cell is mediated by small membrane-bound vesicles (Palade 1975) . In addition to their cargo, these vesicles contain proteins on their surfaces that direct the vesicle to its proper target. The SNARE (~oluble NSF attachment protein receptor) hypothesis states that a protein on the vesicle (v-SNARE) pairs with a protein on the target membrane (t-SNARE), allowing the general fusion factor NSF and SNAPs to bind and fuse the two membranes (SSllner et al. 1993b ). The v-SNAREs show homology with the synaptic vesicle protein VAMP/synaptobrevin, and t-SNAREs are homologous to either syntaxin or SNAP-25 (synaptosomal associated protein of 25 kD). Indeed, biochemical evidence has shown that the recognition step is mediated by the sequential interactions of these and other proteins at the target membrane in a SNARE complex (S611ner et al. 1993a; Sogaard et al. 1994 ). However, a molecular description of this event, as well as the subsequent fusion of the two membranes, remains to be determined. Furthermore, components of the SNARE complex may be regulated by small GTP-binding proteins that act prior to the assembly of this complex (Lian et al. 1994) .
The yeast Saccharomyces cerevisiae has proven to be fruitful in elucidating the molecular aspects of membrane traffic. It has been shown that many of the proteins involved in this process in yeast have homologs in higher eukaryotie organisms, including mammals (Ferro-Novick and Jahn 1994) , indicating that the mechanism of membrane traffic is highly conserved. Highlighting this point is the ability of yeast proteins to functionally replace their mammalian counterparts (Wilson et ai. 1989; Griff et al. 1992) . The genetically tractable nature of yeast has allowed the identification of many mutants in the yeast secretory pathway, which in turn has allowed the identification of related proteins in mammalian cells.
Our laboratory has taken a combined genetic and biochemical approach to decipher the mechanism by which endoplasmic reticulum (ER)-to-Golgi transport vesicles target and fuse with the cis-Golgi compartment. To achieve our goal, we have employed a variety of genetic screens to identify new genes whose products function in this aspect of the secretory pathway. These screens have led to the identification of BET1, BET2, BET3, BOSI, and several uncharacterized
genes. An analysis of the BET and BOS gene products in a cell-free in vitro assay that faithfully reproduces ER-to-Golgi transport (see below) has shown that these proteins play a key role in vesicle targeting and fusion.
MATERIALS AND METHODS

Immunoprecipitation of the SNARE complex.
Yeast cells were grown in YPD medium to early log phase and converted to spheroplasts as described previously (Ruohola et al. 1988; Groesch et al. 1992 ). The spheroplasts were regenerated for 1 hour at 37~ and lysed. After the lysate was spun at 120,000g for 1 hour, the supernatants were collected and diluted to a protein concentration of 2 mg/ml with Buffer A (20 mM HEPES, pH 7.4, 100 mM KCI, 1 mM DTT, 2 mM EDTA, 0.5 mM ATP, 0.5% Triton, and Ix Pie). For immunoprecipitation, 40 ~tg of affinity-pu-'fied anti-Boslp antibody was added to 1 ml of lysate and incubated for 2 hours. The antigen/antibody complexes were precipitated with protein-A-Sepharose, and the beads were washed extensively and solublized in Ix sample buffer as described by Lian et al. (1994) . Samples were electrophoresed and analyzed by Western blot analysis using anti-Sec22p and anti-Sed5p antibodies.
Immunofluoreseence. Immunofluorescence was performed according to the method of Pringle et al. (1991) . Briefly, wild-type yeast cells were grown at 25~ in YPD to early exponential phase and fixed with 3.7% formaldehyde. The fixed cells were converted to spheroplasts and permeabilized with 0.5% SDS. The permeabilized cells were treated with affinity-purified anti-Sec22p antibody (1:5 dilution) or anti-Kar2p serum (1:10,000 dilution) followed by staining with fluorescein (DTAF)-conjugated donkey anti-rabbit IgG (Jackson Immunoresearch Laboratory).
In vitro transport assay. In performing the transport assay, donor permeabilized yeast cells (PYCs), wild-type cytosol, and acceptor Golgi membranes were prepared as described previously (Ruohola et al. 1988; Groesch et al. 1992) . PYCs made from Sec22pdepleted cells were always prepared from cells that were grown at 30~ Each transport reaction was performed in a total volume of 60 ~tl that contained 60 p.g of PYCs, 1 mg of an S1 fraction, and 5 p.l of energy mix (12 mM ATP, 1.2 mM GTP, 240 mM creatine phosphate, and 2.4 mg/ml creatine kinase). 5 Ixl of apyrase (400 units/ml) or 2 txg of anti-Sec22p antibody was added as indicated in Figures 2 and 3. Reactions were incubated on ice for 20 minutes, then at 20~ for 90 minutes before the addition of concanavalin A-Sepharose. Quantitation of the released pro-a-factor was performed as described by Lian and Ferro-Novick (1993) .
RESULTS AND DISCUSSION
Reconstitution of ER-to-Golgi Transport In Vitro
To study the mechanism of vesicle targeting and fusion at a biochemical level, we developed an in vitro assay that reconstitutes transport between the ER and Golgi apparatus (Ruohola et al. 1988; Groesch et al. 1990) . In this assay, yeast cells are first converted to spheroplasts and resuspended in a hypotonic buffer. This permeabilizes the cells (referred to as PYC), washes out soluble factors required for transport, and renders the endogenous Golgi inactive for vesicle consumption. The marker protein used in this assay is the yeast mating pheromone a-factor. A precursor form of a-factor, prepro-ct-factor, is translated in vitro in a yeast translation lysate as a protein that migrates at 19 kD on SDS-PAGE. This protein is posttranslationally translocated into the ER of the PYCs where, following signal sequence cleavage and the addition of three Nlinked oligosaccharides, it then migrates at 26 kD. When an S1 fraction (supernatant of a yeast lysate centrifuged at 1000g) and an ATP-regenerating system are provided to the PYCs, vesicles that bud from the ER are released from the cells to target and fuse with exogenously added Golgi. Addition of high-mannose side chains to the 26-kD form of pro-a-factor in an early Golgi compartment leads to, initially, a 28-kD form of the protein, which is then converted to a heterogeneous high-molecular-weight smear on SDS polyacrylamide gels (see Fig. 3 ). The S1 can be further divided by centrifugation at 120,000g into a high-speed supernatant (HSS), which supplies the factors necessary for transport, and a high-speed pellet (HSP). The HSP provides the Golgi necessary for vesicle consumption. Incubation of PYCs with the HSS leads to the production of functional ER-to-Golgi transport vesicles that are readily separated from the PYCs by centrifugation.
Betlp: An Integral ER Membrane Protein Required for ER-to-Golgi Transport
The betl-1 mutant was originally identified using a [3H]mannose suicide selection (Newman and Ferro-Novick 1987) . It was subsequently shown that SLY12, a gene cloned as a high-copy suppressor of the loss of YPT1, a small Ras-related GTP-binding protein (Das-cher et al. 1991) , was in fact BET! (Newman et al. 1992) . BET1 encodes a type I! integral membrane protein of 142 amino acids with a membrane-spanning domain at its extreme carboxyl terminus. This mutant displays defects in secretion and accumulates ER forms of secretory proteins as well as carboxypeptidase Y (CPY), a vacuolar protein. Morphologically, betl-1 exhibits dilated ER and shows a modest accumulation of small (50 nm) vesicles thought to represent intermediates in ER-to-Golgi transport. On a genetic level, BET1 displays interactions with BOS1 and SEC22 (Newman et al. 1990 ), two other genes encoding ER membrane proteins, as well as YPT1. In fact, BOS1 was identified as a gene that could suppress the growth defect associated with the bet1-1 mutant in a gene-dosage-dependent fashion (Newman et al. 1990 ). In addition, both BETI and BOS1 are capable of suppressing the sec22-3 mutant, and a betl see22 double mutant is inviable. These interactions indicate that the aforementioned gene products act either on the same pathway or on parallel pathways in ER-to-Golgi transport.
Subcellular fractionation has shown that Betlp copurifies with the ER (Newman et al. 1992 ), a site which is well suited for it to influence ER-to-Golgi transport. However, since Boslp resides on the ER as well as the ER-to-Golgi transport vesicles (see below), several studies were undertaken to examine whether Betlp was also a constituent of these vesicles. In one study, PYC were incubated with a HSS to produce functional transport vesicles. The vesicles were immunoisolated using an anti-Boslp antibody and the components were examined by Western blot analysis. Although Boslp, Sec22p, and Yptlp were all found on the transport vesicles, Betlp was conspicuous by its absence (Lian and Ferro-Novick 1993) . A subsequent study, in which nonfunctional transport vesicles were produced using Yptlp-deficient cytosol, showed that Betlp was a component of these vesicles (Rexach et al. 1994) , whereas the mutant Yptlp was not. These vesicles could be rendered competent for fusion by the addition of wild-type cytosol, which provides functional Yptlp. These results suggest that the localization of Betlp may be dependent on the activity of Yptlp.
The Role of Boslp and Sec22p in ER-to-Golgi Transport
Boslp and Sec22p are two small membrane proteins that are structurally related to synaptobrevin, the v-SNARE in nerve terminals (Jessell and Kandel 1993) . BOS1 was originally isolated by its ability to suppress the growth and secretion defects of the betl-1 and sec22-3 mutants (Newman et al. 1990 ). It encodes a 27-kD type II membrane protein that is essential for growth (Shim et al. 1991) . At the amino acid level, Boslp is 23% identical to synaptobrevin, and 27% identical to the SNC1 gene product that is the proposed v-SNARE for post-Golgi transport vesicles (Gerst et al. 1992; Protopopov et al. 1993 ). Cells de-
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Cold Spring Harbor Laboratory on November 12, 2010 -Published by symposium.cshlp.org Downloaded from pleted of Boslp fail to transport pro-a-factor and CPY to the Golgi apparatus and accumulate ER and ER-to~ Golgi transport vesicles (Shim et al. 1991) , indicating that Boslp is a constituent of the transport machinery that acts at an early stage of the secretory pathway. Recently, the role of Boslp in ER-to-Golgi transport has been dissected in detail (Lian and Ferro-Novick 1993; Lian et al. 1994 ). On the basis of functional studies and its similarity with synaptobrevin, it has been proposed to be the v-SNARE of ER-to-Golgi transport vesicles (Ferro-Novick and Jahn 1994) . Three lines of evidence support this hypothesis. First, Boslp resides on the ER as well as the ER-to-Golgi transport vesicles (Newman et al. 1992; Lian and Ferro-Novick 1993) . Second, Boslp specifically functions on vesicles and not on other compartments. Its activity is required for the docking and fusion of ER-derived transport vesicles with the Golgi apparatus, but not for the release of carrier vesicles from the ER (Lian and Ferro-Novick t993). Third, Boslp was found to be a component of a SNARE complex that includes SedSp and several other proteins (Lian et al. 1994; Sogaard et al. 1994 ). Sed5p, a homolog of syntaxin residing on the cis-Golgi stack, is the putative t-SNARE in ER-to-Golgi transport (Banfield et al. 1994 ). These results imply that Boslp, the v-SNARE, modulates the docking and fusion of ER-derived vesicles with the Golgi apparatus through specific pairing with its cognate t-SNARE, Sed5p.
SEC22 was identified in a screen for temperaturesensitive mutants defective in secretion (Novick et al. 1980) . It encodes a 25-kD transmembrane protein with a similar topology to Boslp, and it contains a region just before its transmembrane-spanning domain that is significantly homologous to synaptobrevin. Unlike BOS1, SEC22 is dispensable for cellular growth. Cells lacking Sec22p are cold-sensitive and temperaturesensitive, but grow well at 30~ (Dascher et al. 1991; Lian et al. 1994) . As such, Sec22p is unlikely to play a critical role in intracellular vesicle transport, However, genetic studies have revealed that SEC22 displays strong interactions with several genes required for transport between the ER and Golgi apparatus, including BET1, BOSI, BET3, and YPT1 (Newman et al. 1990; Lian et al. 1994; Rossi et al. 1995) , suggesting that Sec22p acts in concert with the products of these genes to mediate vesicular transport. The observation that Yptlp appears to regulate the association of Boslp and Sec22p on the ER-derived transport vesicles reinforces this notion (Lian et al. 1994) .
To understand the role of Sec22p on the secretory pathway, it is necessary to know at which stage its activity is required and how this activity corresponds with the function of other proteins that interact with Sec22p. For this purpose, we analyzed the intracellular distribution of Sec22p, its interactions with other proteins, and its activity in vesicle budding and fusion events.
In wild-type yeast cells where intracellular transport is rapid and constitutive, vesicle budding and fusion occur efficiently. Under such conditions, the ER-derived v-SNAREs only associate with the Golgi-bound t-SNARE transiently. The majority of the v-SNAREs dwell on the ER, unbound to the t-SNARE, which resides on the cis-Golgi complex. Therefore, as a v-SNARE of the ER-to-Golgi transport vesicles, Sec22p would be expected to reside mainly on the ER. We used indirect immunofluorescence to examine the localization of Sec22p in wild-type yeast cells. We found that Sec22p (Fig. 1A,B ) colocalizes with Kar2p (Fig. 1C,D) , an ER-resident protein, indicating that Sec22p, like Boslp, resides on the ER. However, it is worthwhile to note that even though Boslp and Sec22p colocalize on the ER, they do not interact with each other on this compartment (Lian et al. 1994 ). This interaction takes place only during or after the carrier vesicle is released from the ER and is believed to play an important role in subsequent docking and fusion events.
To test the role of Sec22p in ER-to-Golgi transport, donor PYCs prepared from wild-type or Sec22pdepleted cells (grown at 30~ were assayed for their ability to release pro-a-factor. As shown in Figure 2 , PYCs from Sec22p-depleted cells formed vesicles as efficiently as wild type (Fig. 2, compare lane 1 with lane  3) . Furthermore, addition of anti-Sec22p antibody in the assay had no effect on vesicle budding (Fig. 2, compare lane 1 with lanes 2 and 4) . This result indicates that Sec22p is not required for the budding of pro-afactor-containing vesicles from donor PYC. We then investigated the role of Sec22p in the subsequent docking and fusion event. As shown in Figure 3 , the PYCs from Sec22p-depleted cells are capable of transporting pro-a-factor to the Golgi complex to an extent similar to that of wild type (Fig. 3, compare lane 1 with lane 3) , indicating that vesicle docking and fusion are fully active in the absence of Sec22p. However, when anti-Sec22p antibody was added to the assay, it completely blocked the outer chain extension of pro-a-factor in wild-type, but not in Sec22p-depleted PYCs (Fig. 3,  compare lanes 2 and 4) . One possible explanation for these apparently contradictory results is that Sec22p does not play a critical role in the docking and fusion event, but still is a part of the SNARE complex. As such, anti-Sec22p antibody would be targeted to the SNARE complex, and therefore, in some way, interfere with docking and/or fusion. The fact that anti- Sec22p antibody fails to block outer chain addition in the absence of Sec22p supports this hypothesis (Fig. 3,  lane 4) .
To demonstrate that Sec22p is a component of the ER-to-Golgi SNARE complex, detergent-treated yeast-cell extracts were precipitated with anti-Boslp antibody, and the presence of Sec22p was examined by Western blot analysis. If Sec22p is a component of this docking/fusion complex, then it should coprecipitate with Boslp under conditions in which the complex accumulates. Previous studies have shown that the SNARE complex accumulates in secl8 mutant cells when fusion is blocked (Sogaard et al. 1994) . We examined secl8-1 and two other temperature-sensitive mutants, secl7-1 and sec22-3, that are blocked in vesicle targeting and fusion at 37~ for the accumulation of the SNARE complex. Figure 4 shows the results of this analysis. In wild-type cells where vesicle fusion occurs efficiently and SNARE complexes fail to accumulate to a significant extent, Sec22p and Sed5p do not coprecipitate with Boslp (Fig. 4, lane 1) . However, Sec22p coprecipitates with Boslp and Sed5p in secl8-1 after a shift to 37~ which blocks vesicle fusion (Fig. 4,  lane 2) . This complex also accumulates in the seclT-1 mutant (Fig. 4, lane 3) , but to a lesser extent than in secl8-1, suggesting that the SNARE complex is formed but not stable when Secl7p is inactive. Some accumulation of Sec22p in the SNARE complex is also observed in sec22 mutant cells (Fig. 4, lane 4) . However, this amount is significantly reduced (Fig. 4, lane 4) .
Apparently, Sec22p is not absolutely required for vesicle docking and fusion. However, the above results imply that it acts to facilitate the assembly of the SNARE complex. The accessory role of Sec22p is also supported by genetic results. First, Sec22p is dispensable, which makes it unlikely to be the sole v-SNARE for ER-to-Golgi transport (Dascher et al. 1991) . Second, overproduction of BOS1 dramatically restores the growth defect of Sec22p-depleted cells at 34~ whereas overexpression of SEC22 cannot substitute for the loss of BOS1 (Newman et al. 1990; Lian et al. 1994) . It is likely that Sec22p participates in the formation of the SNARE complex, perhaps by stabilizing the pairing between Boslp and Sed5p. In the absence of Sec22p, the SNARE complex assembles inefficiently.
Isolation and Characterization of the bet3-1 Mutant
In a search for additional factors that might act in concert with Betlp, Sec22p, Yptlp, and Boslp, a screen was performed to identify mutants that are synthetically lethal in combination with the betl-1 mutant. Synthetic lethality is frequently observed when the corresponding gene products act in a similar transport step or are redundant. This approach has led to the identification of a novel temperature-sensitive secretory mutant that is blocked in ER-to-Golgi transport, bet3-1 (Rossi et al. 1995) . As previously reported for betl-1 and other ER-accumulating mutants, in bet3-1 the secretion of invertase is rapidly blocked upon a shift to the nonpermissive temperature, and invertase accumulates as the 80-kD ER form. Similar blocks were observed when the transport of a-factor and CPY was followed (Rossi et al. 1995) . As was found for betl-1, when secretion is blocked in bet3-1 mutant cells, dilated ER membranes build up (Newman and Ferro-Novick 1987) . Additionally, the accumulation of smaller (-60 nm) and larger (-110 nm) vesicles was apparent (Rossi et al. 1995) . Whereas the smaller profiles appeared similar in size to the vesicles that accumulate in other ER-to-Golgi-blocked mutants (Kaiser and Schekman 1990) , the simultaneous appearance of the larger vesicles was reminiscent of the morphology of two other mutants that function at more than one step in the yeast secretory pathway, bet2-1 and secl9-1 (Rossi et al. 1991; Garrett et al. 1994) .
Besides the secretion defect and the morphological alteration observed in betl-1 and bet3-1, another striking similarity between the two mutants is the nature of their genetic interactions. Like betl-1, bet3-1 could be partially suppressed by the overproduction of BET1, SEC22, YPT1, or BOS1. Furthermore, haploid double mutants carrying mutations in BET3 and BET1, or SEC21, SEC22, YPT1, respectively, were inviable at a temperature (25~ at which each of the single mutants was viable (Rossi et al. 1995) , supporting the idea that Betlp and Bet3p may act at a similar step.
Cloning of the BET3 gene by complementation of the bet3-1 temperature-sensitive growth phenotype revealed an open reading frame that encodes a hydrophilic protein of 22 kD (Rossi et al. 1995) . Bet3p also displays significant sequence similarity (36% identity) to a Caenorhabditis elegans protein of unknown function, indicating that it is highly conserved. Gene disruption analysis in yeast has shown that BET3 is an essential gene (Rossi.et al. 1995) .
Since genetic and morphology studies, as well as in vivo transport experiments, suggested a role for Bet3p in the late stages of ER-to-Golgi transport, we determined whether Bet3p is a component of the ER-to-Golgi SNARE complex. As discussed above, this multiprotein complex becomes apparent when vesicle fusion is blocked in the sec18 mutant. It contains Boslp, Sec22p, Sed5p, and several unidentified proteins (S,gaard et al. 1994) . To determine whether Bet3p is part of this complex, anti-Boslp antibody was used to immunoprecipitate the SNARE complex. Although Sec22p and Sed5p were found to coimmunoprecipitate with Boslp, Bet3p did not. Interestingly, although the SNARE complex accumulates in secl8 mutant extracts, it was not found in the bet3-1 mutant (Rossi et al. 1995) , suggesting that Bet3p might be required for its formation. Additionally, the Boslp/Sec22p complex, which accumulates in secretory mutants that accumulate ER-to-Golgi transport vesicles (Lian et al. 1994) , could not be detected in bet3-1 mutant cells (Rossi et Press Cold Spring Harbor Laboratory on November 12, 2010 -Published by symposium.cshlp.org Downloaded from al. 1995 . These findings are consistent with the idea that Bet3p may act prior to the formation of the SNARE complex.
Whereas the phenotypic characterization of the bet3-1 mutant clearly suggests an important role for Bet3p in ER-to-Golgi transport, as mentioned before, genetic and morphological studies indicate that Bet3p fulfills a more general function in the secretory pathway. For example, both ER-to-Golgi and post-Golgi secretory vesicles appear to accumulate in the bet3-1 mutant at 37~ Furthermore, BET3 interacts genetically with several late-acting SEC genes (sec2-41 and sec4-8). Due to the largely hydrophilic nature of the Bet3 protein sequence, it is likely that Bet3p is a soluble protein. Therefore, it could play a role in multiple stages of intracellular membrane traffic events.
Currently, we are investigating whether endocytotic membrane traffic to the vacuole is impaired in bet3-1 mutant cells. Using 35S-labeled a-factor (a mating pheromone) as a marker for receptor-mediated endocytosis (Riezman 1993) , we followed its internalization and endocytotic delivery to the vacuole in bet3-I and wild-type cells. Whereas internalization of the pheromone can be measured by analyzing its protection after an acid wash, transport to the vacuole is followed by a-factor degradation. Upon binding of a-factor to cells at 4~ internalization and degradation were studied in cells incubated at 30~ the nonpermissive growth temperature for bet3-1 cells. This revealed that both pheromone internalization and degradation occurred with similar kinetics in mutant and wild-type cells. Preincubating mutant cells for 20 minutes at 30~ before a-factor binding and internalization did not result in a delay or inhibition of a-factor degradation (B. Singer-Kriiger and S. Ferro-Novick, unpubl.). These findings suggest that Bet3p is not required for endocytosis.
Prenylation Is Required for the Function of Rab Proteins
In yeast, Yptlp and Sec4p are two members of the Rab family of small GTP-binding proteins. They are involved in the regulation of the exocytotic pathway in which Yptlp functions at an early stage and Sec4p acts later in post-Golgi transport . Like their mammalian homologs, both proteins are found to associate with membrane compartments, but neither of them possesses a transmembrane domain. The ability to associate with membranes is conferred by the addition of 20-carbon geranylgeranyl groups onto their carboxy-terminal cysteine residues. This event, called geranylgeranylation, is catalyzed by the type-II geranylgeranyl transferase (GGTase-lI) (Rossi et al. 1991; Seabra et al. 1992) .
GGTase-II modifies Rab proteins that terminate in either a CC or CXC motif. It catalyzes the covalent attachment of geranylgeranyl groups onto terminal cysteine residues, thereby providing a membrane anchor for otherwise soluble proteins. GGTase-II is one of three prenyltransferases that have been identified in eukaryotie cells. The other two prenyltransferases, farnesyltransferase (FTase) and type-I geranylgeranyltransferase (GGTase-I), modify proteins ending in a CXXX motif. Both enzymes are heterodimers that contain a and 13 subunits (Schafer and Rine 1992) . GGTase-II differs from the other two transferases not only in its substrate specificity, but also in its subunit composition. It is composed of three subunits, an a/13 heterodimer and an escort protein (previously called component A) (Seabra et al. 1992; Jiang and Ferro-Novick 1994) . The a/13 heterodimer comprises the catalytic component. However, unlike the FTase and GGTase-I, which binds and transfers an isoprenoid group onto its protein substrate efficiently (Seabra et al. 1991) , the a/13 heterodimer of GGTase-II binds geranylgeranyl diphosphate (GGPP), but only displays limited transferase activity in the absence of the escort protein (Jiang et al. 1993) . The escort protein of the GGTase-II acts as an accessory protein that binds and presents protein substrate to the catalytic component (Andres et al. 1993) . After modification, it delivers the Rab protein to its membrane compartment (Alexandrov et al. 1994) . In yeast, the 13 subunit of the enzyme is encoded by the BET2 gene. It is a 36.6-kD hydrophilic protein that shares approximately 34% amino acid identity with the 13 subunits of the other two transferases (Rossi et al. 1991; Andres et al. 1993; Jiang et al. 1993) . Another yeast gene, BET4 (originally called MAD2), encodes the a subunit, which is a homolog to the a subunit of the other transferases (Li et al. 1993) . The third subunit, the escort protein, is the product of the MRS6 gene and shares about 30% identity with Rab GDI (GDP dissociation inhibitor), a GTP/GDP exchange factor (Garrett et al. 1994) . The similarity between these proteins reflects the fact that they both bind to Rabs. All three genes are essential for cellular growth.
In wild-type cells, about 50% of the Yptlp and 80-90% of the Sec4p are bound to membranes, and the remainder is found in the soluble fraction (Rossi et al. 1991) . The cellular distribution of these proteins is a prerequisite for maintaining their function. When the distribution of Yptlp and Sec4p was examined in bet2 mutant cells, the majority was found in the soluble fraction (Rossi et al. 1991) , indicating a defect in membrane association. Like yptl-1 mutant cells, bet2-1 is blocked in ER-to-Golgi transport (Rossi et al. 1991 ), suggesting that the defect in membrane association impedes the function of Yptlp. Because Yptlp acts at an earlier stage than Sec4p in the secretory pathway, the block in membrane traffic in bet2-1 is a consequence of a malfunction of Yptlp. The same transport defect was also observed in the bet4-2 mutant and in cells that are depleted of Mrs6p (Li et al. 1993; Jiang and Ferro-Novick 1994) . These findings suggest that prenylation plays an important role in mediating the function of Yptlp and Sec4p.
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Cold Spring Harbor Laboratory on November 12, 2010 -Published by symposium.cshlp.org Downloaded from Unlike integral membrane proteins that reside permanently on membranes, membrane-bound prenylated proteins, such as Yptlp and Sec4p, are released from membranes. In wild-type cells, a fraction of these small GTP-binding proteins is always found in the cytosol. The cytosolic forms are believed to associate with a soluble protein, called GDI (Garrett et al. 1994) . Studies with Sec4p have suggested a cycle of localization in which the soluble fraction binds to newly formed vesicles on donor membranes, and is subsequently transferred to the acceptor compartment before it is recycled back through the cytoplasm to bind to a new round of vesicles ). It is not clear how this reversible membrane association corresponds to the function of these proteins. However, the cycle of localization is found to be coupled to the cycle of GTP binding, hydrolysis, and nucleotide exchange, and therefore is likely to play a critical role in regulating the function of these small GTP-binding proteins.
CONCLUDING REMARKS
The preceding sections have summarized our recent work on the role of the BET and BOS gene products in ER-to-Golgi transport in yeast. Recent findings from our laboratory and other laboratories, on the mechanism by which vesicles target and fuse with their acceptor compartment, have greatly propelled our understanding of this process at a molecular level. The rapid pace of discovery in this field serves to heighten our awareness of the complexities of secretion and stimulates our curiosity in this process. Our approach has proven powerful in this endeavor and will continue to be instrumental in furthering our knowledge of secretion.
